Table 2 Brain areas showing significant changes in activation after duloxetine treatment in oxaliplatin-treated macaques.
From: Brain activity changes in a macaque model of oxaliplatin-induced neuropathic cold hypersensitivity
Area | Hemisphere | Z value | x | y | z (mm) |
---|---|---|---|---|---|
After duloxetine treatment (Post-oxaliplatin, 10 °C–37 °C) > Intact (10 °C–37 °C) | |||||
Cb | Left | 3.63 | 8 | −12 | −6 |
V1 | Left | 3.43 | −10 | 24 | 2 |
TFO | Left | 3.12 | 8 | −2 | −6 |
Before > After duloxetine treatment (Post-oxaliplatin, 10 °C–37 °C) | |||||
STG | Left | 3.89 | 20 | 20 | −10 |
MI | Right | 3.49 | −8 | 4 | 20 |
SII/Ins | Right | 3.35 | −16 | 22 | 2 |
Cb | Left | 2.93 | 6 | −8 | −12 |